Clinical Trial

AI-assisted GNW on Adolescent Emotional Distress

Completed
View on ClinicalTrials.gov →
Summary
This cluster-randomized controlled trial aims to evaluate the efficacy of an AI-assisted Guided Narrative Writing (AI-GNW) in alleviating emotional distress among adolescents. Classes will be randomized in a 1:1:1 ratio to one of three arms-AI-GNW, a no-feedback GNW (NF-GNW), or a Neutral Writing Group (NWG)-and will complete a three-day writing intervention. On the first day, participants in both GNW conditions will recount a negative experience and reflect on their thoughts and feelings; on the second day, they will focus exclusively on the negative aspects of that experience; and on the third day, they will explore its positive dimensions. In contrast, NWG participants will objectively document their previous day's daily routine. After each session, those in the AI-GNW arm will receive individualized, AI-generated feedback, whereas NF-GNW participants will proceed without feedback.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-29.
Status change: Active, Not Recruiting → Completed 2026-06-06
Trial Details
NCT Number NCT07105137
Lead Sponsor Peking University
Conditions Emotional Disturbance, Emotional Regulation, Insomnia
Enrollment 486 participants
Start Date 2025-05-19
Primary Completion 2025-10-25 (estimated)
Study Completion 2025-10-25 (estimated)
Updated on ClinicalTrials.gov 2026-06-10